Literature DB >> 20850706

A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression.

Matthew Ough1, Jose Velasco, Tina J Hieken.   

Abstract

BACKGROUND: Core needle biopsy (CNB) is used increasingly not only to diagnose breast cancer, but to determine tumor histology, grade and marker expression, select neoadjuvant therapy, and predict sentinel lymph node status. Thus, we undertook this study to evaluate the accuracy of CNB as a predictor of breast cancer histology and marker expression.
METHODS: We identified 209 Breast Cancer Registry cases with a preoperative CNB and reviewed all clinicopathologic data for accuracy. Statistical analysis was performed with statistical software.
RESULTS: CNB unequivocally showed cancer in 93%. Exact tumor histology concordance was 86%. Ductal carcinoma in situ on CNB was upgraded to invasive cancer in 23%. Concordance was substantial for estrogen receptor expression (88%, κ = .71), but kappa values were less than .6 for tumor grade, mitotic rate, progesterone receptor (PR), Ki-67, HER-2/neu, and p53 expression.
CONCLUSIONS: Reliance on CNB grade and marker expression for critical decision making may be inadvisable. Further study is warranted to optimize breast cancer patient care.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20850706     DOI: 10.1016/j.amjsurg.2010.02.015

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

1.  Comparison of Core Needle Biopsy and Excision Specimens for the Accurate Evaluation of Breast Cancer Molecular Markers: a Report of 1003 Cases.

Authors:  Jie Chen; Zu Wang; Qing Lv; Zhenggui Du; Qiuwen Tan; Di Zhang; Bingjun Xiong; Helin Zeng; Juxiang Gou
Journal:  Pathol Oncol Res       Date:  2017-01-10       Impact factor: 3.201

2.  Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers.

Authors:  Aswin Shanmugalingam; Kerry Hitos; Shrenik Hegde; Ali Al-Mashat; Nirmala Pathmanathan; Senarath Edirimmane; T Michael Hughes; Nicholas K Ngui
Journal:  Breast Cancer Res Treat       Date:  2022-02-28       Impact factor: 4.872

3.  Reliability of receptor assessment on core needle biopsy in breast cancer patients.

Authors:  S C Seferina; M Nap; F van den Berkmortel; J Wals; A C Voogd; V C G Tjan-Heijnen
Journal:  Tumour Biol       Date:  2012-12-27

4.  Accuracy of prognostic and predictive markers in core needle breast biopsies compared with excisional specimens.

Authors:  Mohammad Motamedolshariati; Bahram Memar; Mohsen Aliakbaian; Mohammad T Shakeri; Mohammad Samadi; Ali Jangjoo
Journal:  Breast Care (Basel)       Date:  2014-05       Impact factor: 2.860

5.  Association of estrogen receptor, progesterone receptor and HER2 following neoadjuvant systemic treatment in breast cancer patients undergoing surgery.

Authors:  Y-M Tsai; H-M Hsu; C-J Chen; K-F Hsu; H-L Fan; H Chang; D-C Chan; J-C Yu
Journal:  Ir J Med Sci       Date:  2013-06-12       Impact factor: 1.568

6.  Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients.

Authors:  Wen-Kai Ge; Ben Yang; Wen-Shu Zuo; Gang Zheng; Ying-Qi Dai; Chao Han; Li Yang; Mei-Zhu Zheng
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

7.  Accuracy of estrogen and progesterone receptor assessment in core needle biopsy specimens of breast cancer.

Authors:  Ramesh Omranipour; Sadaf Alipour; Maryam Hadji; Forouzandeh Fereidooni; Issa Jahanzad; Khojasteh Bagheri
Journal:  Iran Red Crescent Med J       Date:  2013-06-05       Impact factor: 0.611

8.  Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.

Authors:  Hyung Sun Kim; Seho Park; Ja Seung Koo; Sanghwa Kim; Jee Ye Kim; Sanggeun Nam; Hyung Seok Park; Seung Il Kim; Byeong-Woo Park
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

9.  DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.

Authors:  Serena Monti; Marco Aiello; Mariarosaria Incoronato; Anna Maria Grimaldi; Michela Moscarino; Peppino Mirabelli; Umberto Ferbo; Carlo Cavaliere; Marco Salvatore
Journal:  Contrast Media Mol Imaging       Date:  2018-01-17       Impact factor: 3.161

10.  Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry.

Authors:  Kiho You; Sungmin Park; Jai Min Ryu; Isaac Kim; Se Kyung Lee; Jonghan Yu; Seok Won Kim; Seok Jin Nam; Jeong Eon Lee
Journal:  J Breast Cancer       Date:  2017-09-22       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.